Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma
Open Access
- 7 June 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (6) , e0269432
Abstract
Clear cell renal cell carcinoma (ccRCC) alters metabolic signals frequently, leading to mitochondrial dysfunction, such as increase of glycolysis and accumulation of lipid. Sirtuin3 (SIRT3) is a key factor for the regulation of both mitochondrial integrity and function. SIRT3 is downregulated and contributes in both cancer development and progression in ccRCC. The aim of this study is to investigate SIRT3-regulated mitochondrial biogenesis in ccRCC. SIRT3 overexpression alone reduced glucose uptake rate and enhanced membrane potential in mitochondria. ccRCC with overexpressed SIRT3 further improved the lethal effects when combined with anticancer drugs (Resveratrol, Everolimus and Temsirolimus). Cell viability was markedly decreased in a dose-dependent manner when treated with resveratrol or mTOR inhibitors in SIRT3 overexpressing ccRCC. In conclusion, SIRT3 improved mitochondrial functions in ccRCC through metabolic reprogramming. Mitochondrial reprogramming by SIRT3 regulation improves the sensitivity to anticancer drugs. The combination of SIRT3 and resveratrol functioned synergistically lethal effect in ccRCC.Keywords
Funding Information
- National Research Foundation of Korea (2018R1D1A1B07050131)
- Yonsei University College of Medicine (6-2021-0099)
This publication has 35 references indexed in Scilit:
- SIRT3 and cancer: Tumor promoter or suppressor?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α DestabilizationCancer Cell, 2011
- Sirtuin regulation of mitochondria: energy production, apoptosis, and signalingTrends in Biochemical Sciences, 2010
- Recent progress in the biology and physiology of sirtuinsNature, 2009
- Grade-dependent Proteomics Characterization of Kidney CancerMolecular & Cellular Proteomics, 2009
- Fatty Acid Synthase Over Expression is an Indicator of Tumor Aggressiveness and Poor Prognosis in Renal Cell CarcinomaJournal of Urology, 2008
- Expression of GLUT1 in Primary Renal TumorsAmerican Journal of Clinical Pathology, 2007
- Resveratrol stimulates AMP kinase activity in neuronsProceedings of the National Academy of Sciences, 2007
- Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1αCell, 2006